Cleaning procedures at Getinge's N.J. plant trigger FDA warning

08/25/2010 | Clinica (subscription required)

The FDA issued a warning letter to Getinge regarding issues with its vascular graft cleaning procedures at its production plant in Wayne, N.J., and a discrepancy related to the 2006 recall of the Hemashield vascular graft. Getinge CEO Johan Malmquist said the warning would not affect the production and marketing of its products at the facility, and that the company hopes to resolve the issues by the end of the year.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC